Variant report
Variant | esv3437947 |
---|---|
Chromosome Location | chr16:30831351-30832349 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs4889492 | chr16:30831366-30831367 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs539702673 | chr16:30831377-30831378 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs113967554 | chr16:30831378-30831379 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs576554284 | chr16:30831379-30831380 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs544322277 | chr16:30831432-30831433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555823912 | chr16:30831439-30831440 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs146201411 | chr16:30831517-30831518 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs574160027 | chr16:30831647-30831648 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs184215588 | chr16:30831725-30831726 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs4889493 | chr16:30831729-30831730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs367729906 | chr16:30831754-30831755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs188326008 | chr16:30831773-30831774 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs370356971 | chr16:30831775-30831776 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs76242002 | chr16:30831793-30831794 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs559674586 | chr16:30831795-30831796 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs528433400 | chr16:30831797-30831798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546963126 | chr16:30831799-30831800 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs112386274 | chr16:30831823-30831824 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs527593357 | chr16:30831901-30831902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs536116773 | chr16:30831923-30831924 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs568895084 | chr16:30831938-30831939 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs568507844 | chr16:30832000-30832001 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs372709617 | chr16:30832086-30832087 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs564352993 | chr16:30832098-30832099 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376916530 | chr16:30832102-30832103 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs550334410 | chr16:30832129-30832130 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs3833424 | chr16:30832220-30832221 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
28 | rs568586213 | chr16:30832273-30832274 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
29 | rs529380936 | chr16:30832296-30832297 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
30 | rs547997504 | chr16:30832306-30832307 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
31 | rs547820093 | chr16:30832323-30832324 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565923486 | chr16:30832329-30832330 | Weak transcription Enhancers Bivalent Enhancer ZNF genes & repeats | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Hodgkin''s lymphoma | 20651079 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Melanoma | 18172304 | CNVD |
Breast cancer | 16608533 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 22566537 | CNVD |
Intellectual disability | 22566537 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 17603634 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Lung cancer | 18438408 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21509527 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 21858162 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Mental retardation | 19951919 | CNVD |
Colorectal cancer | 16272173 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Bladder cancer | 21909424 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21785460 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Breast cancer | 21990379 | CNVD |
Astrocytoma | 22246337 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Epilepsy | 22499536 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Autism | 22513405 | CNVD |
Autism | 22958593 | CNVD |
Autism | 18184952 | CNVD |
Autism | 19966786 | CNVD |
Autism | 21394203 | CNVD |
Autism | 21969575 | CNVD |
Autism | 22241247 | CNVD |
Autism | 20970697 | CNVD |
Autism | 20942916 | CNVD |
Epilepsy | 20970697 | CNVD |
Intellectual disability | 22045946 | CNVD |
Mental retardation | 19966786 | CNVD |
Developmental delay | 20808231 | CNVD |
Obesity | 20808231 | CNVD |
Autism | 18923514 | CNVD |
Obesity | 21881559 | CNVD |
Obesity | 21956041 | CNVD |
Autism | 20659124 | CNVD |
Mental retardation | 21062444 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 21285140 | CNVD |
Schizophrenia | 22885689 | CNVD |
Schizophrenia | 20553308 | CNVD |
Schizophrenia | 20970697 | CNVD |
Schizophrenia | 20433910 | CNVD |
Schizophrenia | 22241247 | CNVD |
Autism | 19242545 | CNVD |
Primary central nervous system lymphoma | 21088137 | CNVD |
Intracranial ependymoma | 16609018 | CNVD |
Schizophrenia | 21399695 | CNVD |
Autism | 21956041 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Autism | 22067053 | CNVD |
Autism | 18156158 | CNVD |
Mental retardation | 20152051 | CNVD |
Autism | 19218893 | CNVD |
Autism | 21289514 | CNVD |
Schizophrenia | 19855392 | CNVD |
neurodevelopmental Syndrome | 20503337 | CNVD |
Benign familial neonatal-infantile seizures | 21060786 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Cancer | 21183584 | CNVD |
Low-grade fibromyxoid sarcoma | 21536545 | CNVD |
Breast cancer | 21045282 | CNVD |
Neuroblastoma | 20406844 | CNVD |
Autism | 19050728 | CNVD |
Epilepsy | 20923578 | CNVD |
Psychiatric disorder | 19050728 | CNVD |
Schizophrenia | 19348701 | CNVD |
Attention deficit hyperactivity disorder | 19097825 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19955444 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 19571808 | CNVD |
Breast cancer | 20409316 | CNVD |
Severe combined immunodeficiency | 19097825 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Autism | 18522746 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Prostate cancer | 18632612 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:30826200-30832000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr16:30826200-30832200 | Weak transcription | Ovary | ovary |
3 | chr16:30826400-30844800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr16:30826600-30832600 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
5 | chr16:30826600-30835200 | Weak transcription | Gastric | stomach |
6 | chr16:30826600-30835200 | Weak transcription | Stomach Mucosa | stomach |
7 | chr16:30826800-30832000 | Weak transcription | HepG2 | liver |
8 | chr16:30831800-30833400 | Weak transcription | Brain Angular Gyrus | brain |
9 | chr16:30832000-30832400 | Weak transcription | Esophagus | oesophagus |
10 | chr16:30832000-30832600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
11 | chr16:30832000-30832600 | Enhancers | HepG2 | liver |
12 | chr16:30832200-30832400 | ZNF genes & repeats | Ovary | ovary |
13 | chr16:30832200-30832600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
14 | chr16:30832200-30832600 | Bivalent Enhancer | Foreskin Fibroblast Primary Cells skin02 | Skin |